Sevelamer Versus Calcium Carbonate in Incident Hemodialysis Patients: Results of an Open-Label 24-Month Randomized Clinical TrialBiagio Di Iorio, Antonio Bellasi, Donald A. Molony et al.|American Journal of Kidney Diseases|2013Cited by 177
Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease PatientsNicholas C Chesnaye, Chiara Somma, Karolina Szummer et al.|Journal of the American Heart Association|2019Cited by 73
Epicardial adipose tissue and coronary artery calcium predict incident myocardial infarction and death in HIV-infected patientsPaolo Raggi, Giovanni Guaraldi, Antonella Santoro et al.|Journal of cardiovascular computed tomography|2015Cited by 38
Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD PatientsChava L. Ramspek, Carin Wallquist, Rosemarijn Boekee et al.|Kidney International Reports|2022Cited by 18
Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD studyMatteo Ruggeri, Biagio Di Iorio, Antonio Bellasi et al.|Journal of Nephrology|2014Cited by 18